http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 27 Aug 2026 16:51:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html <p>BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.</p> <p><strong>Wells Fargo 21</strong><strong>st</strong><strong> Annual Healthcare Conference </strong><br/>Tuesday, September 8, 2026, in Boston<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET</p> <p><strong>Morgan Stanley 24</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Wednesday, September 16, 2026, in New York City<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET</p> <p><strong>19</strong><strong>th</strong><strong> Annual Barrington Research Virtual Fall Investment Conference </strong><br/>Tuesday, September 22, 2026<br/>Dorian LeBlanc, CFO, time to be announced</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html Thu, 27 Aug 2026 16:51:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html <p>BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.</p> <p><strong>Wells Fargo 21</strong><strong>st</strong><strong> Annual Healthcare Conference </strong><br/>Tuesday, September 8, 2026, in Boston<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET</p> <p><strong>Morgan Stanley 24</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Wednesday, September 16, 2026, in New York City<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET</p> <p><strong>19</strong><strong>th</strong><strong> Annual Barrington Research Virtual Fall Investment Conference </strong><br/>Tuesday, September 22, 2026<br/>Dorian LeBlanc, CFO, time to be announced</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html Thu, 27 Aug 2026 16:51:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html <p>BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.</p> <p><strong>Wells Fargo 21</strong><strong>st</strong><strong> Annual Healthcare Conference </strong><br/>Tuesday, September 8, 2026, in Boston<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET</p> <p><strong>Morgan Stanley 24</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Wednesday, September 16, 2026, in New York City<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET</p> <p><strong>19</strong><strong>th</strong><strong> Annual Barrington Research Virtual Fall Investment Conference </strong><br/>Tuesday, September 22, 2026<br/>Dorian LeBlanc, CFO, time to be announced</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html Thu, 27 Aug 2026 16:51:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html <p>BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.</p> <p><strong>Wells Fargo 21</strong><strong>st</strong><strong> Annual Healthcare Conference </strong><br/>Tuesday, September 8, 2026, in Boston<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET</p> <p><strong>Morgan Stanley 24</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Wednesday, September 16, 2026, in New York City<br/>Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET</p> <p><strong>19</strong><strong>th</strong><strong> Annual Barrington Research Virtual Fall Investment Conference </strong><br/>Tuesday, September 22, 2026<br/>Dorian LeBlanc, CFO, time to be announced</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+at+Upcoming+Investor+Conferences+in+September/26990801.html Thu, 27 Aug 2026 16:51:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html <p>BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech &amp; Diagnostics 1x1 Conference on Tuesday, August 11, 2026.</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.</p> <p>Contact: <br/>Sandra http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html Thu, 06 Aug 2026 17:15:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html <p>BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech &amp; Diagnostics 1x1 Conference on Tuesday, August 11, 2026.</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.</p> <p>Contact: <br/>Sandra http://www.streetinsider.com/Press+Releases/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html Thu, 06 Aug 2026 17:15:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html <p>BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech &amp; Diagnostics 1x1 Conference on Tuesday, August 11, 2026.</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.</p> <p>Contact: <br/>Sandra http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html Thu, 06 Aug 2026 17:15:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html <p>BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech &amp; Diagnostics 1x1 Conference on Tuesday, August 11, 2026.</p> <p><strong>About LeMaitre</strong></p> <p>LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.</p> <p>Contact: <br/>Sandra http://www.streetinsider.com/Globe+Newswire/LeMaitre+to+Participate+in+the+11th+Annual+Needham+Virtual+MedTech+%26amp%3B+Diagnostics+1x1+Conference/26885544.html Thu, 06 Aug 2026 17:15:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Analyst+PT+Change/LeMaitre+Vascular+%28LMAT%29+PT+Lowered+to+%2494+at+Wells+Fargo/26870475.html Wells Fargo analyst Nathan Treybeck lowered the price target on LeMaitre Vascular (NASDAQ: LMAT) to $94.00 (from $104.00) while maintaining a Equal Weight rating. http://www.streetinsider.com/Analyst+PT+Change/LeMaitre+Vascular+%28LMAT%29+PT+Lowered+to+%2494+at+Wells+Fargo/26870475.html Wed, 05 Aug 2026 07:58:11 -0400 LMAT http://www.streetinsider.com/Downgrades/Barrington+Research+Downgrades+LeMaitre+Vascular+%28LMAT%29+to+Market+Perform/26870357.html <p>Barrington Research analyst Mike Petusky downgraded LeMaitre Vascular (NASDAQ: LMAT) from Outperform to Market Perform.</p><p>For an analyst ratings summary and ratings history on LeMaitre Vascular <a href="http://www.streetinsider.com/rating_history.php?q=LMAT">click here</a>. For more ratings news on LeMaitre Vascular <a href="http://www.streetinsider.com/stock_lookup_news.php?q=LMAT&amp;type=analyst">click here</a>.</p><p>Shares of LeMaitre Vascular closed at $105.78 yesterday.</p> http://www.streetinsider.com/Downgrades/Barrington+Research+Downgrades+LeMaitre+Vascular+%28LMAT%29+to+Market+Perform/26870357.html Wed, 05 Aug 2026 07:36:05 -0400 LMAT http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LEMAITRE+VASCULAR+INC+++++For%3A+Jun+30/26869708.html si-local-file:///var/storage/secattach/20260805/26869708.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LEMAITRE+VASCULAR+INC+++++For%3A+Jun+30/26869708.html Wed, 05 Aug 2026 06:31:00 -0400 LMAT O.01772186 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LEMAITRE+VASCULAR+INC+++++For%3A+Jun+30/26869708.html si-local-file:///var/storage/secattach/20260805/26869708.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LEMAITRE+VASCULAR+INC+++++For%3A+Jun+30/26869708.html Wed, 05 Aug 2026 06:31:00 -0400 LMAT O.01772186 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LEMAITRE+VASCULAR+INC+++++For%3A+Aug+04/26867268.html si-local-file:///var/storage/secattach/20260804/26867268.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LEMAITRE+VASCULAR+INC+++++For%3A+Aug+04/26867268.html Tue, 04 Aug 2026 16:39:00 -0400 LMAT O.01772186 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LEMAITRE+VASCULAR+INC+++++For%3A+Aug+04/26867268.html si-local-file:///var/storage/secattach/20260804/26867268.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LEMAITRE+VASCULAR+INC+++++For%3A+Aug+04/26867268.html Tue, 04 Aug 2026 16:39:00 -0400 LMAT O.01772186 http://www.streetinsider.com/Earnings/Lemaitre+Vascular+%28LMAT%29+Misses+Q2+EPS+by+7c/26867008.html <p>Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.74, $0.07 worse than the analyst estimate of $0.81. Revenue for the quarter came in at $70.4 million versus the consensus estimate of $71.47 million.</p><p>For earnings history and earnings-related data on Lemaitre Vascular (LMAT) <a href="http://www.streetinsider.com/ec_earnings.php?q=LMAT">click here</a>.</p> http://www.streetinsider.com/Earnings/Lemaitre+Vascular+%28LMAT%29+Misses+Q2+EPS+by+7c/26867008.html Tue, 04 Aug 2026 16:31:12 -0400 LMAT http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Press+Releases/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html <p>BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.</p> <p><strong>Q2 2026:</strong></p> <ul><li>Sales $70.4mm, +10% (+10% organic) vs. Q2 2025<br/></li><li>Gross margin 72.1% (+210 bps)<br/></li><li>Op. income $20.4mm (+26%) <br/></li><li>Op. margin 29%<br/></li><li>EPS $0.74 (+23%)<br/></li><li>Cash up $9.0mm sequentially to $376.2mm<br/><br/></li></ul> <p>Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the http://www.streetinsider.com/Globe+Newswire/LeMaitre+Q2+2026+Financial+Results/26866134.html Tue, 04 Aug 2026 16:05:00 -0400 A.14567740 LMAT O.01772186 O.47131358 http://www.streetinsider.com/SEC+Filings/Form++144++++++++LEMAITRE+VASCULAR+INC++++++++++++++++++Filed+by%3A+Ross+Bridget+A/26835004.html si-local-file:///var/storage/secattach/20260729/26835004.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++LEMAITRE+VASCULAR+INC++++++++++++++++++Filed+by%3A+Ross+Bridget+A/26835004.html Wed, 29 Jul 2026 16:08:00 -0400 LMAT O.01772186 http://www.streetinsider.com/SEC+Filings/Form++144++++++++LEMAITRE+VASCULAR+INC++++++++++++++++++Filed+by%3A+Ross+Bridget+A/26835004.html si-local-file:///var/storage/secattach/20260729/26835004.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++LEMAITRE+VASCULAR+INC++++++++++++++++++Filed+by%3A+Ross+Bridget+A/26835004.html Wed, 29 Jul 2026 16:08:00 -0400 LMAT O.01772186